Body
(FDA: Washington) -- U.S. Food and Drug Administration investigators and U.S. marshals recently seized all implantable medical devices from Shelhigh Inc., Union, New Jersey, after finding significant deficiencies in the company’s manufacturing processes. The deficiencies may compromise the safety and effectiveness of the products, particularly their sterility.
…
Want to continue?
Log in or create a FREE account.
By logging in you agree to receive communication from Quality Digest.
Privacy Policy.
Add new comment